SNU-423(人肝癌细胞)
CBP60216
询 价
索取STR
产品描述
产品数据库
I. General information | |
Synonyms: | SNU-423 |
Background: | SNU-423 was derived in 1990 by J.-G. Park and associates from a primary hepatocellular carcinoma taken from a Korean patient who had been treated by transcatheter arterial embolization with lipoidol plus doxorubicin. Tumor cells were initially cultured in ACL-4 medium supplemented with 5% heat-inactivated fetal bovine serum. After establishment, cultures were maintained in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum. |
Species: | Homo sapiens, human |
Tissue: | liver |
Disease: | grade III/IV, pleomorphic hepatocellular carcinoma |
Gender: | male, 40 years, Asian |
Morphology: | epithelial |
Growth Mode: | adherent |
Doubling Time: | 72 hrs |
DNA Profile: | Amelogenin: X,Y CSF1PO: 11,12 D13S317: 10,13 D16S539: 9 D5S818: 10 D7S820: 12 THO1: 6,9 TPOX: 8 vWA: 15 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+10%FBS SNU-423完全培养基,#CBP60216M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | Blood Type B; Rh + |
Comments: | Grossly, the original tumor was single nodular with perinodular extensions. Histologically, it was trabecular type. The cultured cells are multinucleated. Hepatitis B virus (HBV) DNA was detected by Southern blot hybridization. HBV genomic RNA was not expressed. For more information, please contact Cobioer (4008-750-250) |